Globus Medical (GMED) Competitors $82.92 -0.40 (-0.48%) (As of 12/9/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends GMED vs. EW, RMD, IDXX, DXCM, STE, PODD, HOLX, BAX, MASI, and TFXShould you be buying Globus Medical stock or one of its competitors? The main competitors of Globus Medical include Edwards Lifesciences (EW), ResMed (RMD), IDEXX Laboratories (IDXX), DexCom (DXCM), STERIS (STE), Insulet (PODD), Hologic (HOLX), Baxter International (BAX), Masimo (MASI), and Teleflex (TFX). These companies are all part of the "health care equipment" industry. Globus Medical vs. Edwards Lifesciences ResMed IDEXX Laboratories DexCom STERIS Insulet Hologic Baxter International Masimo Teleflex Edwards Lifesciences (NYSE:EW) and Globus Medical (NYSE:GMED) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, profitability, earnings, dividends, risk, valuation, analyst recommendations, institutional ownership and media sentiment. Do analysts rate EW or GMED? Edwards Lifesciences presently has a consensus target price of $78.35, indicating a potential upside of 9.37%. Globus Medical has a consensus target price of $89.73, indicating a potential upside of 8.17%. Given Edwards Lifesciences' higher probable upside, equities analysts plainly believe Edwards Lifesciences is more favorable than Globus Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Edwards Lifesciences 0 Sell rating(s) 16 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.38Globus Medical 1 Sell rating(s) 2 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.67 Does the MarketBeat Community believe in EW or GMED? Edwards Lifesciences received 770 more outperform votes than Globus Medical when rated by MarketBeat users. Likewise, 71.00% of users gave Edwards Lifesciences an outperform vote while only 67.79% of users gave Globus Medical an outperform vote. CompanyUnderperformOutperformEdwards LifesciencesOutperform Votes133271.00% Underperform Votes54429.00% Globus MedicalOutperform Votes56267.79% Underperform Votes26732.21% Is EW or GMED more profitable? Edwards Lifesciences has a net margin of 70.82% compared to Globus Medical's net margin of 3.69%. Edwards Lifesciences' return on equity of 20.76% beat Globus Medical's return on equity.Company Net Margins Return on Equity Return on Assets Edwards Lifesciences70.82% 20.76% 15.27% Globus Medical 3.69%9.98%7.92% Does the media prefer EW or GMED? In the previous week, Edwards Lifesciences had 85 more articles in the media than Globus Medical. MarketBeat recorded 96 mentions for Edwards Lifesciences and 11 mentions for Globus Medical. Globus Medical's average media sentiment score of 1.06 beat Edwards Lifesciences' score of 0.30 indicating that Globus Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edwards Lifesciences 31 Very Positive mention(s) 8 Positive mention(s) 35 Neutral mention(s) 4 Negative mention(s) 3 Very Negative mention(s) Neutral Globus Medical 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better earnings & valuation, EW or GMED? Edwards Lifesciences has higher revenue and earnings than Globus Medical. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEdwards Lifesciences$6.00B7.04$1.40B$6.9310.34Globus Medical$1.57B7.20$122.87M$0.67123.81 Do institutionals and insiders believe in EW or GMED? 79.5% of Edwards Lifesciences shares are held by institutional investors. Comparatively, 95.2% of Globus Medical shares are held by institutional investors. 1.3% of Edwards Lifesciences shares are held by insiders. Comparatively, 18.5% of Globus Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more risk and volatility, EW or GMED? Edwards Lifesciences has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500. Comparatively, Globus Medical has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500. SummaryEdwards Lifesciences beats Globus Medical on 11 of the 18 factors compared between the two stocks. Ad Paradigm Press[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. Get Globus Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for GMED and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GMED vs. The Competition Export to ExcelMetricGlobus MedicalSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$11.30B$4.41B$4.99B$20.26BDividend YieldN/A43.48%7.68%3.47%P/E Ratio123.8113.3879.4437.28Price / Sales7.2048.151,375.5418.42Price / Cash23.1055.0734.3818.55Price / Book2.834.704.765.64Net Income$122.87M$13.41M$114.61M$981.24M7 Day Performance-1.13%-2.86%5.43%1.82%1 Month Performance2.56%-2.98%121.02%3.73%1 Year Performance78.35%35.41%156.56%24.74% Globus Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GMEDGlobus Medical4.5985 of 5 stars$82.92-0.5%$90.36+9.0%+79.1%$11.29B$1.57B123.765,000Analyst ForecastPositive NewsEWEdwards Lifesciences4.6929 of 5 stars$70.06-1.8%$77.25+10.3%+3.4%$41.32B$6.00B10.1319,800Analyst RevisionRMDResMed4.8589 of 5 stars$245.19-1.5%$225.70-7.9%+48.3%$35.99B$4.69B32.989,980Analyst RevisionPositive NewsIDXXIDEXX Laboratories4.97 of 5 stars$426.72+1.2%$546.56+28.1%-18.0%$34.94B$3.66B40.6711,000Positive NewsDXCMDexCom4.988 of 5 stars$77.99-0.1%$104.59+34.1%-33.6%$30.46B$3.62B46.709,600Analyst ForecastPositive NewsSTESTERIS4.9685 of 5 stars$219.82+0.3%$253.00+15.1%+7.7%$21.70B$5.33B49.9018,179Positive NewsPODDInsulet4.3588 of 5 stars$266.78-0.1%$253.27-5.1%+36.4%$18.71B$1.98B45.683,000Analyst ForecastPositive NewsHOLXHologic4.9107 of 5 stars$79.50+0.1%$89.91+13.1%+10.2%$18.47B$4.03B23.876,990Insider TradeBAXBaxter International4.527 of 5 stars$33.65-0.2%$40.91+21.6%-12.0%$17.18B$14.81B168.5660,000MASIMasimo3.9968 of 5 stars$173.07+0.3%$167.00-3.5%+62.7%$9.27B$2.05B118.995,200Positive NewsTFXTeleflex4.8529 of 5 stars$194.63+0.9%$259.25+33.2%-20.1%$9.04B$3.03B37.8414,500Positive News Related Companies and Tools Related Companies Edwards Lifesciences Alternatives ResMed Alternatives IDEXX Laboratories Alternatives DexCom Alternatives STERIS Alternatives Insulet Alternatives Hologic Alternatives Baxter International Alternatives Masimo Alternatives Teleflex Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:GMED) was last updated on 12/9/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWaveBot: The Automated Trading Tool for This Bull MarketThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Globus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Globus Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GMED Stock Alerts